This study will evaluate and compare the processes involved in decision-making between the following groups: (1) patients with substance abuse and no schizophrenia, (2) patients with schizophrenia and no substance abuse, (3) dual-diagnosis patients (with both substance abuse and schizophrenia) and (4) healthy controls (with neither substance abuse nor schizophrenia).